Hyperfine Announces Completion Of Enrollment In Contrast PMR Study Of Swoop Portable MRI; Plans FDA 510(k) Submission By End Of 2026 For First Indication Expansion
Share
Why It Matters
Hyperfine finished testing its portable MRI machine with contrast dye. The company plans to ask the FDA for approval by end of 2026.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.